Cocaine (COC) Rapid Test

A Cocaine (COC) Rapid Test is a quick urine screening test used to detect cocaine-related substances in a urine sample. In drug testing, COC commonly refers to cocaine or cocaine metabolite screening. Many cocaine urine assays are designed to detect benzoylecgonine, a major urinary metabolite commonly used for cocaine screening.

The Cocaine (COC) Rapid Test is intended for preliminary qualitative screening of cocaine-related metabolites in urine specimens. It is designed for professional screening environments where fast initial results are required.

Applications

• Drug of abuse screening programs
• Clinical toxicology laboratories
• Hospital screening support
• Workplace drug screening programs
• Rehabilitation and recovery centers
• Forensic screening settings
• Institutional drug monitoring workflows
• International diagnostic product distribution

• Urine is one of the most common specimen types for drug-of-abuse screening because it can show evidence of recent or past drug exposure.
• For cocaine testing, urine screening commonly focuses on metabolites because cocaine itself is processed quickly in the body.
• The presence of cocaine-related metabolites in urine can support preliminary screening for cocaine exposure, but final interpretation should follow professional testing protocols.

Instructions

• Rapid urine-based screening
• 300ng/ml cut-off sensitivity
• Designed for cocaine drug-of-abuse testing
• Easy-to-read qualitative result format
• Suitable for professional screening programs
• Useful for laboratories, institutions, and occupational health testing
• Supports preliminary detection before confirmatory analysis
• International product-page suitability for B2B healthcare markets

Note

The Cocaine (COC) Rapid Test should be used as a screening tool only. Initial drug test results are considered preliminary, and positive screening results may require confirmatory laboratory testing.

The Cocaine (COC) Rapid Test uses a rapid urine screening method for qualitative detection of cocaine-related markers. It is designed to provide a preliminary screening result at the stated 300ng/ml cut-off.

Benefits

• Urine-based rapid screening format
• 300ng/ml cocaine cut-off
• Designed for COC drug screening
• Suitable for professional diagnostic use
• Supports fast preliminary results
• Useful for toxicology and compliance workflows
• Applicable for laboratories, clinics, and institutions
• Supports international drug screening requirements

The Cocaine (COC) Rapid Test is designed for urine specimens. Urine is widely used in drug screening because it is practical for detecting drug exposure in professional screening workflows.

Guidance

• Use urine specimens only
• Use clean sample collection procedures
• Follow the product insert carefully
• Treat all urine samples as potentially biohazardous
• Interpret results within the stated reading window
• Use confirmatory testing where required by clinical, legal, workplace, or institutional policy

Note

A rapid screening result should be considered preliminary unless confirmed by a validated laboratory method where required.

The Cocaine (COC) Rapid Test by LARKSOIS Pharma has a stated cut-off of 300ng/ml. This means the test is designed to screen for cocaine-related metabolites in urine at or above the validated threshold. LARKSOIS Pharma should mention the exact performance details according to the final product insert, technical file, and regulatory documentation.

• The COC rapid urine test plays an important role in drug-of-abuse screening because cocaine misuse can create serious health, safety, workplace, and legal concerns.
• In professional testing programs, rapid screening helps identify samples that may require further laboratory evaluation.
• For global buyers, the Cocaine COC Rapid Test 300ng/ml is an important product for diagnostic portfolios, drug testing panels, rehabilitation support, workplace safety programs, and forensic screening applications.

Steps

• Bring the test device and urine specimen to the recommended testing condition
• Open the sealed pouch only when ready to test
• Collect urine using a clean sample collection procedure
• Apply the urine specimen according to the product insert
• Wait for the test reaction to complete within the instructed time
• Read the result within the approved interpretation window
• Dispose of used materials according to laboratory safety rules

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the Cocaine (COC) Rapid Test.

Positive

A positive result suggests that cocaine-related metabolites may be present in the urine specimen at or above the stated cut-off. Positive results are preliminary unless confirmed by an appropriate laboratory method.

Negative

A negative result suggests that cocaine-related metabolites were not detected or were below the test cut-off at the time of testing. A negative result does not replace clinical or professional judgment.

Invalid

If the control indicator does not appear, the result is invalid. The test should be repeated with a new device and fresh urine specimen according to the product insert.

Instructions

• Store in a cool and dry place
• Keep away from direct sunlight
• Do not freeze the test kit
• Keep sealed until use
• Use before the expiry date printed on the pack
• Keep away from excessive heat and moisture

Instructions

• For professional screening use only
• Use only urine specimens as specified
• Do not use expired or damaged test kits
• Follow the instruction leaflet supplied with the product
• Do not interpret the result after the recommended reading time
• Positive results should be confirmed by a specific laboratory method
• Results should be interpreted along with clinical, occupational, or legal context where applicable

LARKSOIS Pharma focuses on reliable pharmaceutical and diagnostic solutions for international healthcare markets. The Cocaine (COC) Rapid Test is positioned for B2B buyers, diagnostic distributors, laboratories, clinics, and institutional drug-testing programs that require practical, rapid, and market-ready screening products.

Advantages

• Clear 300ng/ml cut-off
• Urine specimen compatibility
• Rapid screening format
• Suitable for professional diagnostic programs
• Useful for workplace and institutional testing
• Supports preliminary cocaine screening workflows
• International product positioning under LARKSOIS Pharma